Ocumension Therapeutics's total assets for Q4 2024 were ¥3.97B, an increase of 31.32% from the previous quarter. HK:1477 total liabilities were ¥200.19M for the fiscal quarter, a -22.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.